Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
[2-(1,3-benzodioxol-5-yl)-1-methyl-ethyl]amine
MDA is a psychoactive empathogen from the phenethylamine class, primarily acting through the release of serotonin, dopamine, and norepinephrine. It produces empathogenic, stimulating, and mildly psychedelic effects. The substance is pharmacologically classified as an entactogen and has a moderate risk profile, particularly due to potential cardiovascular and neurotoxic effects with improper use.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Designations
IUPAC: [2-(1,3-benzodioxol-5-yl)-1-methyl-ethyl]amine
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Total duration 6-8 hours
Peak
2-3 hours
Onset
30-60 minutes
Total duration
6-8 hours
After effects
2-4 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, and pre-existing conditions significantly affect outcomes.
Risks
Neurotoxicity
possible
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Some combinations can be dangerous. Research before combining substances.
Serotoninsyndrom: MDA (stärker serotonerg als MDMA) + SSRI
MDA (3,4-Methylendioxyamphetamin) ist der demethylierte Metabolit von MDMA mit stärkerer serotonerger Neurotoxizität und direkter 5-HT2A-agonistischer Aktivität. Als potenter Monoaminfreisetzer birgt die Kombination mit SSRI ein erhöhtes Serotoninsyndrom-Risiko. Die psychedelische Komponente (5-HT2A) kommt bei MDMA nicht vor und kann die Wirkung unvorhersehbar verändern.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.